Vandelaer Antoine, Joubert Michael, Philips Jean-Christophe
Université de Liège, 4000 Liège, Belgique.
Service d'endocrinologie-diabétologie, CHU de Caen, 14000 Caen, France.
Rev Med Suisse. 2022 Aug 24;18(792):1560-1564. doi: 10.53738/REVMED.2022.18.792.1560.
Postprandial hyperglycaemia (PPH) may sometimes be relegated to the background in the treatment of diabetic patients, while its control seems important if not essential to reach an adequate overall glycaemic control. PPH is correlated with glycated haemoglobin and diabetic complications. It is also identified as a cardiovascular risk factor. PPH's monitoring and adequate control are not only a therapeutic goal for diabetes itself but also for reducing associated adverse outcomes other than diabetic complications. PPH is related to the quality of life of patients. Continuous glucose monitoring allows a better appraisal of PPH. The use of new insulin formulations as ultra-fast insulins seems to be the better way to manage post-prandial blood glucose peaks.
餐后高血糖（PPH）在糖尿病患者的治疗中有时可能被置于次要地位，然而，若要实现充分的总体血糖控制，即便并非至关重要，其控制似乎也是很重要的。PPH与糖化血红蛋白及糖尿病并发症相关。它还被认定为一种心血管危险因素。PPH的监测及充分控制不仅是糖尿病本身的治疗目标，也是减少糖尿病并发症以外的相关不良后果的目标。PPH与患者的生活质量相关。持续葡萄糖监测能够更好地评估PPH。使用新型胰岛素制剂如超短效胰岛素似乎是控制餐后血糖峰值的更佳方法。
